Nicholas Saraceno
Editor at Pharmaceutical Commerce
Editor at @pharmacommerce and co-host of #HenleysAndVnecks. Former Tape Op with @CBSSportsRadio. Graduate from @FloridaAtlantic. #OwlNation
Articles
-
6 days ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and looks forward to collaborating closely with Debbie Weitzman of Cardinal Health to strengthen connections across the pharmaceutical supply chain.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader global LogiPharma portfolio, my team now focuses solely on this event. These days, it’s a year-round project—365 days. Once this year’s event wraps, I’ll be thanking our speakers and delegates and immediately starting research conversations for 2026. Before we even draft the agenda, we aim to conduct 150 to 200 hours of research calls.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization and the key priorities he hopes to drive during his tenure. He expresses a strong sense of privilege and responsibility in succeeding Kirk Kaminsky and looks forward to collaborating closely with Debbie Weitzman of Cardinal Health to strengthen connections across the pharmaceutical supply chain.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
PC: When comparing this year to previous years, how would you say the main discussion points of LogiPharma have evolved? Robinson: I’m sure I’m not the only one saying this, but the big one is AI. The pace of growth in machine learning and automation has been incredible—even just compared to last year. We’re seeing a surge in both the number and scale of use cases, and I don’t see that slowing down any time soon.
-
1 week ago |
pharmaceuticalcommerce.com | Nicholas Saraceno
There is a new contract development and manufacturing organization (CDMO) in the marketplace. With the ultimate goal of boosting patient health through its manufacturing services, Meribel Pharma Solutions has officially launched, bringing with it a European network of clients.1The name comes from the Meribel mountain range in the Alps.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 292
- Tweets
- 1K
- DMs Open
- No
On behalf of @Clin_Trials, I’m here reporting live from Philadelphia for #DPHARM2024 on a quest to discover the latest innovations in the clinical research space. Stay tuned for my session coverage and video interviews, as I explore all that the conference has to offer. https://t.co/l3rz8TwwDu
And just like that, another issue of Pharma Commerce is in the books. Our #August issue does a wonderful job of covering the below, alongside an examination of #BigPharma Inventories and a look at the US drug wholesaling market.
🚨Our August issue is LIVE🚨 #Biotech’s achilles’ heel▪️#Pharmacydeserts becoming a national problem▪️Enhancing #patientaccess and #patientsupport through technology▪️and so much more right here ➡️ https://t.co/WjcztUpP9q https://t.co/ZjGBqo1pYR
I'm very proud of all the content that PC's April issue delivers. We dive into the #pharma #coldchain, #patientadherence tools, the role of #PBMs, and much more. And if you happen to be at #LogiPharmaEurope, you can check it out for yourself by grabbing a print copy!
🚨Our April issue is LIVE🚨 Fresh Views on #PAP2024 and Patient Hubs▪️The power of patient #adherence tools in improving the patient journey▪️Navigating changes and trends in the #pharmasupplychain #PostDSCSA ▪️ and so much more right here ➡️https://t.co/TNH9EOFLdY https://t.co/WjlKG4BS3q